SM-09

N/A

Report date: 2023/08/15 18:01:01

Base Information

Drug NameSM-09
Drug Alias NameSM-09
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulants
TargetsB-lymphocyte antigen CD20
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSinomab Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinomab Bioscience Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A